Impact of cardiometabolic risk on symptomatic and functional outcomes in schizophrenia: a 4-year longitudinal study. // Neuroscience Applied. – URL: https://www.sciencedirect.com/science/article/pii/S2772408526000992?dgcid=rss_sd_all
Impact of cardiometabolic risk on symptomatic and functional outcomes in schizophrenia: a 4-year longitudinal study. Neuroscience Applied. https://www.sciencedirect.com/science/article/pii/S2772408526000992?dgcid=rss_sd_all
“Impact of cardiometabolic risk on symptomatic and functional outcomes in schizophrenia: a 4-year longitudinal study.” Neuroscience Applied.
@article{article12886,
title = {Impact of cardiometabolic risk on symptomatic and functional outcomes in schizophrenia: a 4-year longitudinal study},
journal = {Neuroscience Applied},
url = {https://www.sciencedirect.com/science/article/pii/S2772408526000992?dgcid=rss_sd_all}
}